Reduced volume of the putamen in REM sleep behavior disorder patients

Parkinsonism and Related Disorders

Volumn 16, Issue 10, 2010, Pages 645-649

  Ellmore, Timothy M ^a   Hood, Ashley J ^a   Castriotta, Richard J ^a   Stimming, Erin F ^a   Bick, Roger J ^a   Schiess, Mya C ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Parasomnia; Polysomnography; RBD; UPDRS; Volumetric reconstruction

Indexed keywords

ADULT; ARTICLE; BRAIN SIZE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; GRAY MATTER; HUMAN; MALE; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARASOMNIA; PARKINSON DISEASE; PARKINSON DISEASE QUESTIONNAIRE; PREDICTION; PRIORITY JOURNAL; PUTAMEN; QUESTIONNAIRE; UNIFIED PARKINSON DISEASE RATING SCALE;

BRAIN; CAUDATE NUCLEUS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LEWY BODIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYSOMNOGRAPHY; PUTAMEN; REM SLEEP BEHAVIOR DISORDER; RISK;

EID: 78649750583     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2010.08.014     Document Type: Article

References (30)

1. Schenck C.H., Bundlie S.R., Ettinger M.G., Mahowald M.W. Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep 1986 Jun, 9(2):293-308.
2. Schenck C.H., Bundlie S.R., Patterson A.L., Mahowald M.W. Rapid eye movement sleep behavior disorder. A treatable parasomnia affecting older adults. JAMA 1987 Apr 3, 257(13):1786-1789.
3. Schenck C.H., Hurwitz T.D., Mahowald M.W. Symposium: normal and abnormal REM sleep regulation: REM sleep behaviour disorder: an update on a series of 96 patients and a review of the world literature. Journal of Sleep Research 1993 Dec, 2(4):224-231.
4. Schenck C.H., Mahowald M.W. Rapid eye movement sleep parasomnias. Neurologic Clinics 2005 Nov, 23(4):1107-1126.
5. Lai Y.Y., Hsieh K.C., Nguyen D., Peever J., Siegel J.M. Neurotoxic lesions at the ventral mesopontine junction change sleep time and muscle activity during sleep: an animal model of motor disorders in sleep. Neuroscience 2008 Jun 23, 154(2):431-443.
6. Boeve B.F., Silber M.H., Saper C.B., Ferman T.J., Dickson D.W., Parisi J.E., et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 2007 Nov, 130(Pt 11):2770-2788.
7. Albin R.L., Koeppe R.A., Chervin R.D., Consens F.B., Wernette K., Frey K.A., et al. Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology 2000 Nov 14, 55(9):1410-1412.
8. Eisensehr I., Linke R., Noachtar S., Schwarz J., Gildehaus F.J., Tatsch K. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls. Brain 2000 Jun, 123(Pt 6):1155-1160.
9. Postuma R.B., Gagnon J.F., Vendette M., Fantini M.L., Massicotte-Marquez J., Montplaisir J. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 2009 Apr 14, 72(15):1296-1300.
10. Schenck C.H., Bundlie S.R., Mahowald M.W. REM behavior disorder (RBD): delayed emergence of Parkinsonism and/or dementia in 65% of older men initially diagnosed with idiopathic RBD, and an analysis of the minimum and maximum tonic and/or phasic electromyographic abnormalities found during REM sleep. Sleep 2003, 26:A316.
11. Comella C.L., Nardine T.M., Diederich N.J., Stebbins G.T. Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease. Neurology 1998 Aug, 51(2):526-529.
12. Schenck C.H., Mahowald M.W. Polysomnographic, neurologic, psychiatric, and clinical outcome report on 70 consecutive cases with REM sleep behavior disorder (RBD): sustained clonazepam efficacy in 89.5% of 57 treated patients. Cleveland Clinic Journal of Medicine 1990, 57(Suppl.):S9-23.
13. Nunnemann S., Wohlschlager A.M., Ilg R., Gaser C., Etgen T., Conrad B., et al. Accelerated aging of the putamen in men but not in women. Neurobiology of Aging 2009 Jan, 30(1):147-151.
14. Morrish P.K., Sawle G.V., Brooks D.J. Clinical and [18F] dopa PET findings in early Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry 1995 Dec, 59(6):597-600.
15. Whone A.L., Moore R.Y., Piccini P.P., Brooks D.J. Plasticity of the nigropallidal pathway in Parkinson's disease. Annals of Neurology 2003 Feb, 53(2):206-213.
16. Fearnley J.M., Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991 Oct, 114(Pt 5):2283-2301.
17. Iber C., Ancoli-Israel S., Chesson A., Quan S.F. The AASM manual for the scoring of sleep and associated events: rules, terminology, and technical specifics 2007, American Academy of Sleep Medicine, Westchester, IL.
18. Langston J.W., Widner H., Goetz C.G., Brooks D., Fahn S., Freeman T., et al. Core assessment program for intracerebral transplantations (CAPIT). Movement Disorder 1992, 7(1):2-13.
19. Jenkinson C., Fitzpatrick R., Peto V., Greenhall R., Hyman N. The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age and Ageing 1997 Sep, 26(5):353-357.
20. Dale A.M., Fischl B., Sereno M.I. Cortical surface-based analysis. I. Segmentation and surface reconstruction. NeuroImage 1999 Feb, 9(2):179-194.
21. Fischl B., Salat D.H., Busa E., Albert M., Dieterich M., Haselgrove C., et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002 Jan 31, 33(3):341-355.
22. Jovicich J., Czanner S., Han X., Salat D., van der Kouwe A., Quinn B., et al. MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths. NeuroImage 2009 May 15, 46(1):177-192.
23. Desikan R.S., Fischl B., Cabral H.J., Kemper T.L., Guttmann C.R., Blacker D., et al. MRI measures of temporoparietal regions show differential rates of atrophy during prodromal AD. Neurology 2008 Sep 9, 71(11):819-825.
24. Reetz K., Gaser C., Klein C., Hagenah J., Buchel C., Gottschalk S., et al. Structural findings in the basal ganglia in genetically determined and idiopathic Parkinson's disease. Movement Disorder 2009 Jan 15, 24(1):99-103.
25. Jacobsen L.K., Giedd J.N., Gottschalk C., Kosten T.R., Krystal J.H. Quantitative morphology of the caudate and putamen in patients with cocaine dependence. The American Journal of Psychiatry 2001 Mar, 158(3):486-489.
26. Altena E., Vrenken H., Van Der Werf Y.D., van den Heuvel O.A., Van Someren E.J. Reduced orbitofrontal and parietal gray matter in chronic insomnia: a voxel-based morphometric study. Biological Psychiatry 2010 Jan 15, 67(2):182-185.
27. Celle S., Roche F., Peyron R., Faillenot I., Laurent B., Pichot V., et al. Lack of specific gray matter alterations in restless legs syndrome in elderly subjects. Journal of Neurology 2010 Mar, 257(3):344-348.
28. Macey P.M., Henderson L.A., Macey K.E., Alger J.R., Frysinger R.C., Woo M.A., et al. Brain morphology associated with obstructive sleep apnea. American Journal of Respiratory and Critical Care Medicine 2002 Nov 15, 166(10):1382-1387.
29. Takakusaki K., Habaguchi T., Ohtinata-Sugimoto J., Saitoh K., Sakamoto T. Basal ganglia efferents to the brainstem centers controlling postural muscle tone and locomotion: a new concept for understanding motor disorders in basal ganglia dysfunction. Neuroscience 2003, 119(1):293-308.
30. Takakusaki K., Saitoh K., Harada H., Okumura T., Sakamoto T. Evidence for a role of basal ganglia in the regulation of rapid eye movement sleep by electrical and chemical stimulation for the pedunculopontine tegmental nucleus and the substantia nigra pars reticulata in decerebrate cats. Neuroscience 2004, 124(1):207-220.